Eagle Asset Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$34.9M Buy
434,514
+3,227
+0.7% +$229K 0.18% 135
2024
Q2
$29.2M Buy
431,287
+135,608
+46% +$9.19M 0.16% 144
2024
Q1
$21.2M Sell
295,679
-69,458
-19% -$4.64M 0.11% 185
2023
Q4
$22.4M Buy
365,137
+31,480
+9% +$1.87M 0.12% 176
2023
Q3
$19.1M Buy
333,657
+737
+0.2% +$44.5K 0.11% 186
2023
Q2
$19.8M Buy
332,920
+30,557
+10% +$1.83M 0.11% 183
2023
Q1
$18.9M Buy
302,363
+8,325
+3% +$520K 0.11% 168
2022
Q4
$18.7M Sell
294,038
-4,584
-2% -$263K 0.11% 175
2022
Q3
$14.9M Buy
298,622
+122,986
+70% +$6.81M 0.1% 195
2022
Q2
$10.3M Sell
175,636
-372
-0.2% -$20.5K 0.06% 239
2022
Q1
$9.32M Sell
176,008
-9,034
-5% -$522K 0.05% 280
2021
Q4
$11.5M Sell
185,042
-7,925
-4% -$470K 0.05% 288
2021
Q3
$10.8M Sell
192,967
-65,332
-25% -$3.59M 0.05% 303
2021
Q2
$13.5M Buy
258,299
+3,544
+1% +$170K 0.06% 276
2021
Q1
$11M Sell
254,755
-18,937
-7% -$796K 0.05% 299
2020
Q4
$9.54M Sell
273,692
-25,419
-8% -$903K 0.05% 296
2020
Q3
$10.5M Sell
299,111
-1,963
-0.7% -$73K 0.05% 272
2020
Q2
$11M Buy
301,074
+4,847
+2% +$194K 0.06% 267
2020
Q1
$10.9M Buy
296,227
+40,955
+16% +$1.59M 0.07% 258
2019
Q4
$10.3M Buy
255,272
+43,603
+21% +$1.63M 0.05% 316
2019
Q3
$7.34M Sell
211,669
-4,668
-2% -$154K 0.04% 348
2019
Q2
$6.85M Sell
216,337
-4,661
-2% -$139K 0.04% 367
2019
Q1
$6.61M Buy
220,998
+4,244
+2% +$122K 0.04% 362
2018
Q4
$6.69M Buy
216,754
+6,768
+3% +$247K 0.04% 336
2018
Q3
$7.96M Buy
209,986
+15,434
+8% +$584K 0.04% 375
2018
Q2
$7.47M Buy
194,552
+9,785
+5% +$330K 0.04% 371
2018
Q1
$6.23M Sell
184,767
-306,310
-62% -$11.8M 0.03% 389
2017
Q4
$21.6M Sell
491,077
-782,313
-61% -$35.6M 0.12% 236
2017
Q3
$64.6M Sell
1,273,390
-105,456
-8% -$5.39M 0.37% 85
2017
Q2
$72.8M Buy
1,378,846
+37,849
+3% +$2.03M 0.44% 58
2017
Q1
$74.5M Sell
1,340,997
-2,099
-0.2% -$116K 0.47% 53
2016
Q4
$70M Sell
1,343,096
-5,139
-0.4% -$248K 0.46% 55
2016
Q3
$65.1M Buy
1,348,235
+7,453
+0.6% +$377K 0.44% 65
2016
Q2
$74.3M Sell
1,340,782
-77,384
-5% -$4.26M 0.51% 46
2016
Q1
$75.7M Sell
1,418,166
-75,487
-5% -$3.72M 0.53% 39
2015
Q4
$76.9M Sell
1,493,653
-26,899
-2% -$1.34M 0.51% 41
2015
Q3
$68.7M Sell
1,520,552
-88,890
-6% -$4.2M 0.47% 56
2015
Q2
$74.4M Buy
1,609,442
+700,685
+77% +$30.7M 0.42% 75
2015
Q1
$39M Buy
908,757
+807,360
+796% +$30.8M 0.22% 155
2014
Q4
$3.52M Sell
101,397
-5,619
-5% -$186K 0.02% 474
2014
Q3
$3.46M Sell
107,016
-858
-0.8% -$28.7K 0.02% 497
2014
Q2
$3.65M Buy
107,874
+10,813
+11% +$346K 0.02% 511
2014
Q1
$2.64M Buy
97,061
+9,783
+11% +$291K 0.01% 582
2013
Q4
$3.12M Buy
87,278
+12,008
+16% +$399K 0.02% 525
2013
Q3
$2.28M Buy
75,270
+12,831
+21% +$420K 0.01% 624
2013
Q2
$1.82M Buy
+62,439
New +$1.76M 0.01% 620

Other funds holding PBH

Eagle Asset Management's PBH Position: Q3 2024 in Review

Eagle Asset Management increased its Prestige Consumer Healthcare (PBH) stake by 0.75% in Q3 2024, buying an estimated $229K and bringing the position to 434,514 shares worth $34.9M. The position accounts for 0.18% of the portfolio, ranked #135.

Eagle Asset Management first reported a position in PBH in Q2 2013 and has held it in 46 quarters since. The position peaked at $76.9M in Q4 2015. 328 funds tracked by Wall St. Rank hold PBH as of Q3 2024.

  • Eagle Asset Management held 434,514 shares of Prestige Consumer Healthcare worth $34.9M as of Q3 2024.
  • Eagle Asset Management bought 3,227 Prestige Consumer Healthcare shares in Q3 2024, an estimated $229K.
  • Prestige Consumer Healthcare made up 0.18% of Eagle Asset Management's portfolio in Q3 2024, its #135 holding.
  • Eagle Asset Management first reported a position in Prestige Consumer Healthcare in Q2 2013 and has held it in 46 quarters since.
  • Eagle Asset Management's Prestige Consumer Healthcare position peaked at $76.9M in Q4 2015.
  • 328 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2024.

Based on Eagle Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.